Skip to main content

Table 2 The percentages of CD69+ CD19+ cells in myocardium, spleen, and blood in AMI and control mice

From: Are activated B cells involved in the process of myocardial fibrosis after acute myocardial infarction? An in vivo experiment

Group

n

CD19+ CD69+ (%)

Myocardium

Spleen

Blood

AMI 3d

8

10.62 ± 1.62*#

6.05 ± 0.73*#

5.32 ± 0.73*#

Sham 3d

6

3.72 ± 0.51

3.62 ± 0.36

2.29 ± 0.43

AMI 5d

8

22.71 ± 3.43*

12.40 ± 2.07*

6.82 ± 0.77*

Sham 5d

6

3.75 ± 0.29

3.80 ± 0.40

2.76 ± 0.39

AMI 1W

8

7.62 ± 1.74*#

4.02 ± 0.58*#

3.60 ± 0.73#

Sham 1W

6

3.53 ± 0.65

3.71 ± 0.56

2.84 ± 0.55

AMI 2W

8

4.45 ± 0.75#

4.13 ± 0.82#

3.10 ± 0.58#

Sham 2W

6

3.40 ± 0.44

3.58 ± 0.59

2.58 ± 0.67

  1. *P < 0.05, the activated B cell ratio of AMI group was compared with the corresponding subgroups of the Sham group
  2. #P < 0.05, the activated B cell ratio of other subgroups of the AMI group was compared with AMI 5 days subgroups. Data are represented by mean ± standard deviation
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us